STIM - Neuronetics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
65,206
65,206
55,312
49,244
62,656
Cost of Revenue
15,483
15,483
11,653
11,554
15,389
Gross Profit
49,723
49,723
43,659
37,690
47,267
Operating Expenses
Research Development
9,336
9,336
7,923
9,201
13,747
Selling General and Administrative
75,498
75,498
63,300
50,798
60,450
Total Operating Expenses
84,834
84,834
71,223
59,999
74,197
Operating Income or Loss
-35,111
-35,111
-27,564
-22,309
-26,930
Interest Expense
651
4,251
4,019
4,522
3,685
Total Other Income/Expenses Net
2,203
2,203
390
-622
1,571
Income Before Tax
-37,159
-37,159
-31,193
-27,453
-29,044
Income from Continuing Operations
-37,159
-37,159
-31,193
-27,453
-29,044
Net Income
-37,159
-37,159
-31,193
-27,453
-29,044
Net Income available to common shareholders
-37,159
-37,159
-31,193
-27,453
-29,044
Basic EPS
-
-1.38
-1.22
-1.46
-1.58
Diluted EPS
-
-1.38
-1.22
-1.46
-1.58
Basic Average Shares
-
26,900
25,479
18,835
18,380
Diluted Average Shares
-
26,900
25,479
18,835
18,380
EBITDA
-
-31,260
-26,114
-21,990
-24,294